These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 16274789)

  • 1. Histopathologic effects of cidofovir on cartilage.
    Spiegel JH; Andrus JG; Stefanato CM; Heeren T
    Otolaryngol Head Neck Surg; 2005 Nov; 133(5):666-71. PubMed ID: 16274789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of vocal fold injection of cidofovir and bevacizumab in a porcine model.
    Connor MP; Brown A; Palazzolo M; Kunkel J; Eller R; Hartnick C; Maturo S
    JAMA Otolaryngol Head Neck Surg; 2014 Feb; 140(2):155-9. PubMed ID: 24288019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An animal model for cidofovir (HPMPC) toxicity: intraocular pressure and histopathologic effects.
    Taskintuna I; Banker AS; Rao NA; Wiley CA; Flores-Aguilar M; Munguia D; Bergeron-Lynn G; De Clercq E; Keefe K; Freeman WR
    Exp Eye Res; 1997 May; 64(5):795-806. PubMed ID: 9245910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of high-dose vocal fold injection of cidofovir and bevacizumab in a porcine model.
    Ahmed MM; Connor MP; Palazzolo M; Thompson ME; Lospinoso J; O'Connor P; Howard NS; Maturo SC
    Laryngoscope; 2017 Mar; 127(3):671-675. PubMed ID: 27452286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is intralesional cidofovir worthwhile in juvenile recurrent respiratory papillomatosis?
    Sheahan P; Sexton S; Russell JD
    J Laryngol Otol; 2006 Jul; 120(7):561-5. PubMed ID: 16834805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is cidofovir a useful adjunctive therapy for recurrent respiratory papillomatosis in children?
    Peyton Shirley W; Wiatrak B
    Int J Pediatr Otorhinolaryngol; 2004 Apr; 68(4):413-8. PubMed ID: 15013606
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A scheduled protocol for the treatment of juvenile recurrent respiratory papillomatosis with intralesional cidofovir.
    Chhetri DK; Shapiro NL
    Arch Otolaryngol Head Neck Surg; 2003 Oct; 129(10):1081-5. PubMed ID: 14568791
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intralesional cidofovir and surgical excision for laryngeal papillomatosis.
    Naiman AN; Ceruse P; Coulombeau B; Froehlich P
    Laryngoscope; 2003 Dec; 113(12):2174-81. PubMed ID: 14660923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stepped-dose protocol of cidofovir therapy in recurrent respiratory papillomatosis in children.
    Akst LM; Lee W; Discolo C; Knott D; Younes A; Koltai PJ
    Arch Otolaryngol Head Neck Surg; 2003 Aug; 129(8):841-6. PubMed ID: 12925342
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of cidofovir injection for the treatment of recurrent respiratory papillomatosis.
    Lee AS; Rosen CA
    J Voice; 2004 Dec; 18(4):551-6. PubMed ID: 15567056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Local and systemic effects of intralaryngeal injection of cidofovir in a canine model.
    Chhetri DK; Jahan-Parwar B; Hart SD; Bhuta SM; Berke GS; Shapiro NL
    Laryngoscope; 2003 Nov; 113(11):1922-6. PubMed ID: 14603048
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cidofovir plasma assays after local injection in respiratory papillomatosis.
    Naiman AN; Roger G; Gagnieu MC; Bordenave J; Mathaut S; Ayari S; Nicollas R; Bour JB; Garabedian N; Froehlich P
    Laryngoscope; 2004 Jul; 114(7):1151-6. PubMed ID: 15235339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of topical and subconjunctival cidofovir (HPMPC) in an animal model.
    Banker AS; Bergeron-Lynn G; Keefe KS; De Clercq E; Taskintuna I; Freeman WR
    Curr Eye Res; 1998 Jun; 17(6):560-6. PubMed ID: 9663845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of dysplasia in juvenile-onset recurrent respiratory papillomatosis.
    Sajan JA; Kerschner JE; Merati AL; Osipov V; Szabo S; Blumin JH
    Arch Otolaryngol Head Neck Surg; 2010 Jan; 136(1):7-11. PubMed ID: 20083770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential risk factors associated with the use of cidofovir to treat benign human papillomavirus-related disease.
    Donne AJ; Hampson L; He XT; Day PJ; Salway F; Rothera MP; Homer JJ; Hampson IN
    Antivir Ther; 2009; 14(7):939-52. PubMed ID: 19918098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-chlorotaurine is an effective antiviral agent against adenovirus in vitro and in the Ad5/NZW rabbit ocular model.
    Romanowski EG; Yates KA; Teuchner B; Nagl M; Irschick EU; Gordon YJ
    Invest Ophthalmol Vis Sci; 2006 May; 47(5):2021-6. PubMed ID: 16639011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enzymatic recontouring of auricular cartilage in a rabbit model.
    Massengill PL; Goco PE; Norlund LL; Muir-Padilla J
    Arch Facial Plast Surg; 2005; 7(2):104-10. PubMed ID: 15781721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Degrees of dysplasia and the use of cidofovir in patients with recurrent respiratory papillomatosis.
    Gupta HT; Robinson RA; Murray RC; Karnell LH; Smith RJ; Hoffman HT
    Laryngoscope; 2010 Apr; 120(4):698-702. PubMed ID: 20205173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 3.5-Year follow-up of intralesional cidofovir protocol for pediatric recurrent respiratory papillomatosis.
    Chung BJ; Akst LM; Koltai PJ
    Int J Pediatr Otorhinolaryngol; 2006 Nov; 70(11):1911-7. PubMed ID: 16919339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term follow-up of pediatric recurrent respiratory papillomatosis managed with intralesional cidofovir.
    Pransky SM; Albright JT; Magit AE
    Laryngoscope; 2003 Sep; 113(9):1583-7. PubMed ID: 12972938
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.